These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 25933436)

  • 1. Novel Non-Peptide Inhibitors against SmCL1 of Schistosoma mansoni: In Silico Elucidation, Implications and Evaluation via Knowledge Based Drug Discovery.
    Zafar A; Ahmad S; Rizvi A; Ahmad M
    PLoS One; 2015; 10(5):e0123996. PubMed ID: 25933436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular modeling and substrate specificity of discrete cruzipain-like and cathepsin L-like cysteine proteinases of the human blood fluke Schistosoma mansoni.
    Brady CP; Brinkworth RI; Dalton JP; Dowd AJ; Verity CK; Brindley PJ
    Arch Biochem Biophys; 2000 Aug; 380(1):46-55. PubMed ID: 10900131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant expression and localization of Schistosoma mansoni cathepsin L1 support its role in the degradation of host hemoglobin.
    Brady CP; Dowd AJ; Brindley PJ; Ryan T; Day SR; Dalton JP
    Infect Immun; 1999 Jan; 67(1):368-74. PubMed ID: 9864238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-silico analysis of Sirt2 from Schistosoma mansoni: structures, conformations, and interactions with inhibitors.
    Singh R; Singh S; Pandey PN
    J Biomol Struct Dyn; 2016 May; 34(5):1042-51. PubMed ID: 26108803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of Potent Inhibitors of Schistosoma mansoni NAD⁺ Catabolizing Enzyme.
    Jacques SA; Kuhn I; Koniev O; Schuber F; Lund FE; Wagner A; Muller-Steffner H; Kellenberger E
    J Med Chem; 2015 Apr; 58(8):3582-92. PubMed ID: 25803425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular docking to explore the possible binding mode of potential inhibitors of thioredoxin glutathione reductase.
    Huang J; Hua W; Li J; Hua Z
    Mol Med Rep; 2015 Oct; 12(4):5787-95. PubMed ID: 26239395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein Translation Enzyme lysyl-tRNA Synthetase Presents a New Target for Drug Development against Causative Agents of Loiasis and Schistosomiasis.
    Sharma A; Sharma M; Yogavel M; Sharma A
    PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005084. PubMed ID: 27806050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular docking and molecular dynamics study on SmHDAC1 to identify potential lead compounds against Schistosomiasis.
    Singh R; Pandey PN
    Mol Biol Rep; 2015 Mar; 42(3):689-98. PubMed ID: 25663090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of inhibitors of Schistosoma mansoni HDAC8 by combining homology modeling, virtual screening, and in vitro validation.
    Kannan S; Melesina J; Hauser AT; Chakrabarti A; Heimburg T; Schmidtkunz K; Walter A; Marek M; Pierce RJ; Romier C; Jung M; Sippl W
    J Chem Inf Model; 2014 Oct; 54(10):3005-19. PubMed ID: 25243797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of new inhibitors of Schistosoma mansoni PNP by pharmacophore-based virtual screening.
    Postigo MP; Guido RV; Oliva G; Castilho MS; da R Pitta I; de Albuquerque JF; Andricopulo AD
    J Chem Inf Model; 2010 Sep; 50(9):1693-705. PubMed ID: 20695479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening and Phenotypical Characterization of
    Saccoccia F; Brindisi M; Gimmelli R; Relitti N; Guidi A; Saraswati AP; Cavella C; Brogi S; Chemi G; Butini S; Papoff G; Senger J; Herp D; Jung M; Campiani G; Gemma S; Ruberti G
    ACS Infect Dis; 2020 Jan; 6(1):100-113. PubMed ID: 31661956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schistosoma mansoni: differential expression of cathepsins L1 and L2 suggests discrete biological functions for each enzyme.
    Brady CP; Brindley PJ; Dowd AJ; Dalton JP
    Exp Parasitol; 2000 Feb; 94(2):75-83. PubMed ID: 10673343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computer-aided discovery of novel SmDHODH inhibitors for schistosomiasis therapy: Ligand-based drug design, molecular docking, molecular dynamic simulations, drug-likeness, and ADMET studies.
    Ja'afaru SC; Uzairu A; Hossain S; Ullah MH; Sallau MS; Ndukwe GI; Ibrahim MT; Bayil I; Moin AT
    PLoS Negl Trop Dis; 2024 Sep; 18(9):e0012453. PubMed ID: 39264908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual Strategy to Design New Agents Targeting
    Fuchs N; Zimmermann RA; Schwickert M; Gunkel A; Zimmer C; Meta M; Schwickert K; Keiser J; Haeberli C; Kiefer W; Schirmeister T
    ACS Infect Dis; 2024 May; 10(5):1664-1678. PubMed ID: 38686397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drugging the schistosome zinc-dependent HDACs: current progress and future perspectives.
    Marek M; Oliveira G; Pierce RJ; Jung M; Sippl W; Romier C
    Future Med Chem; 2015; 7(6):783-800. PubMed ID: 25996070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular docking and structure-based virtual screening studies of potential drug target, CAAX prenyl proteases, of Leishmania donovani.
    Singh S; Vijaya Prabhu S; Suryanarayanan V; Bhardwaj R; Singh SK; Dubey VK
    J Biomol Struct Dyn; 2016 Nov; 34(11):2367-86. PubMed ID: 26551589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vitro and in Vivo Antischistosomal Activities of Chalcones.
    Pereira VRD; Junior IJA; da Silveira LS; Geraldo RB; de F Pinto P; Teixeira FS; Salvadori MC; Silva MP; Alves LA; Capriles PVSZ; das C Almeida A; Coimbra ES; Pinto PLS; Couri MRC; de Moraes J; Da Silva Filho AA
    Chem Biodivers; 2018 Dec; 15(12):e1800398. PubMed ID: 30276965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cheminformatics models for inhibitors of Schistosoma mansoni thioredoxin glutathione reductase.
    Gaba S; Jamal S; Open Source Drug Discovery Consortium ; Scaria V
    ScientificWorldJournal; 2014; 2014():957107. PubMed ID: 25629082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for the function and inhibition of dihydroorotate dehydrogenase from Schistosoma mansoni.
    de Mori RM; Aleixo MAA; Zapata LCC; Calil FA; Emery FS; Nonato MC
    FEBS J; 2021 Feb; 288(3):930-944. PubMed ID: 32428996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Class of Schistosoma mansoni Histone Deacetylase 8 (HDAC8) Inhibitors Identified by Structure-Based Virtual Screening and In Vitro Testing.
    Simoben CV; Robaa D; Chakrabarti A; Schmidtkunz K; Marek M; Lancelot J; Kannan S; Melesina J; Shaik TB; Pierce RJ; Romier C; Jung M; Sippl W
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29498707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.